Australia markets open in 2 hours 16 minutes

Chugai Pharmaceutical Co., Ltd. (CHGCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
33.270.00 (0.00%)
At close: 11:56AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 54.79B
Enterprise value 50.01B
Trailing P/E 26.01
Forward P/E 24.81
PEG ratio (5-yr expected) 8.50
Price/sales (ttm)7.62
Price/book (mrq)5.21
Enterprise value/revenue 0.04
Enterprise value/EBITDA 0.11

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 333.56%
S&P500 52-week change 323.06%
52-week high 343.72
52-week low 324.91
50-day moving average 338.12
200-day moving average 333.45

Share statistics

Avg vol (3-month) 3483
Avg vol (10-day) 3240
Shares outstanding 51.65B
Implied shares outstanding 61.65B
Float 8639.34M
% held by insiders 159.91%
% held by institutions 119.56%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.56
Forward annual dividend yield 41.68%
Trailing annual dividend rate 380.00
Trailing annual dividend yield 3240.46%
5-year average dividend yield 4N/A
Payout ratio 440.44%
Dividend date 301 Sept 2017
Ex-dividend date 427 June 2024
Last split factor 23:1
Last split date 329 June 2020

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 29.29%
Operating margin (ttm)44.40%

Management effectiveness

Return on assets (ttm)14.44%
Return on equity (ttm)21.34%

Income statement

Revenue (ttm)1.11T
Revenue per share (ttm)675.52
Quarterly revenue growth (yoy)-37.60%
Gross profit (ttm)N/A
EBITDA 470.91B
Net income avi to common (ttm)325.47B
Diluted EPS (ttm)1.28
Quarterly earnings growth (yoy)-11.00%

Balance sheet

Total cash (mrq)738.98B
Total cash per share (mrq)449.13
Total debt (mrq)13.45B
Total debt/equity (mrq)0.83%
Current ratio (mrq)4.74
Book value per share (mrq)988.01

Cash flow statement

Operating cash flow (ttm)409.92B
Levered free cash flow (ttm)317.04B